Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Perspectives in weight control in diabetesSGLT2 inhibitors and GLP-1-glucagon dual agonism
GLP-1, the gut-brain, and brain-periphery axes
Cell Tissue Res
3 However, the latest American Diabetes Association and Kidney Disease: Improving Global Outcomes guidelines now recommend glucagon-like peptide-1 (GLP-1) receptor agonists, with or without metformin, as initial pharmacotherapy for patients with type 2 diabetes who are at high risk for cardiovascular disease, heart failure, or CKD
[CrossRef] [PubMed] [Google Scholar] Implications of GLP-1 agonist use on airway management
US$ 22.19
US$ 29.64
.png)
US$ 27.48
US$ 23.43
US$ 24.21
US$ 25.27
US$ 28.86
